XML 53 R12.htm IDEA: XBRL DOCUMENT v3.20.1
MARKETABLE SECURITITES
3 Months Ended
Mar. 31, 2020
Marketable Securities [Abstract]  
Marketable Securities Disclosure MARKETABLE SECURITIES:
Amortized cost and estimated fair market value of marketable securities classified as available-for-sale (excluding cash equivalents) at March 31, 2020, were as follows:
 
Amortized Cost
 
Gross Unrealized
 
Estimated Fair Market Value
(In thousands)
 
Gains
 
Losses
 
Investments due in 3 months or less:
 
 
 
 
 
 
 
Commercial paper
$
14,869

 
$

 
$

 
$
14,869

Corporate securities
28,104

 
1

 
(21
)
 
28,084

Total
42,973

 
1

 
(21
)
 
42,953

Investments due in 4-12 months:
 
 
 
 
 
 
 
Corporate securities
63,204

 
61

 
(159
)
 
63,106

Total
63,204

 
61

 
(159
)
 
63,106

Investments due in 12 months or greater:
 
 
 
 
 
 
 
Corporate securities
126,375

 
145

 
(396
)
 
126,124

Total
126,375

 
145

 
(396
)
 
126,124

Total marketable securities
$
232,552

 
$
207

 
$
(576
)
 
$
232,183

Accrued interest receivable was $1.7 million at March 31, 2020 and was recorded within prepaid expenses and other current assets on the condensed consolidated balance sheet.
Amortized cost and estimated fair market value of marketable securities classified as available-for-sale (excluding cash equivalents) at December 31, 2019, were as follows:
 
Amortized Cost
 
Gross Unrealized
 
Estimated Fair Market Value
(In thousands)
 
Gains
 
Losses
 
Investments due in 3 months or less:
 
 
 
 
 
 
 
Corporate securities
$
15,934

 
$
18

 
$

 
$
15,952

Total
15,934

 
18

 

 
15,952

Investments due in 4-12 months:
 
 
 
 
 
 
 
Corporate securities
71,223

 
269

 

 
71,492

Total
71,223

 
269

 

 
71,492

Investments due in 12 months or greater:
 
 
 
 
 
 
 
Corporate securities
144,658

 
302

 

 
144,954

Total
144,658

 
302

 
(6
)
 
144,954

Total marketable securities
$
231,815

 
$
589

 
$
(6
)
 
$
232,398


Accrued interest receivable was $1.3 million at December 31, 2019 and was recorded within prepaid expenses and other current assets on the condensed consolidated balance sheet.
The following table summarizes marketable securities classified as available-for-sale (excluding cash equivalents) in a continuous unrealized loss position for which an allowance for credit losses has not been recorded at March 31, 2020 and December 31, 2019:
 
Less Than 12 Months
 
12 Months or Longer
 
Total
(In thousands)
Estimated Fair Market Value
 
Gross Unrealized Losses
 
Estimated Fair Market Value
 
Gross Unrealized Losses
 
Estimated Fair Market Value
 
Gross Unrealized Losses
March 31, 2020
 
 
 
 
 
 
 
 
 
 
 
Corporate securities
$
138,527

 
$
(576
)
 
$

 
$

 
$
138,527

 
$
(576
)
Total marketable securities
$
138,527

 
$
(576
)
 
$

 
$

 
$
138,527

 
$
(576
)
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
Corporate securities
$
13,069

 
$
(6
)
 
$

 
$

 
$
13,069

 
$
(6
)
Total marketable securities
$
13,069

 
$
(6
)
 
$

 
$

 
$
13,069

 
$
(6
)

In the three months ended March 31, 2020, no unrealized losses on marketable securities were recognized in income. The Company does not intend to sell and it is unlikely that it will be required to sell the securities prior to their anticipated recovery. The issuers are high quality (investment grade) and the decline in fair value is largely due to changes in interest rates and other market conditions. Additionally, the issuers continue to make timely interest payments on the marketable securities with the fair value expected to recover as they reach maturity.